Course: Assessment of 4 Doses of SARS-CoV-2 Messenger RNA–Based Vaccine in Recipients of a Solid Organ Transplant
CME Credits: 1.00
Released: 2021-11-24
Anti–SARS-CoV-2 antibodies have been detected in up to approximately 70% of solid organ transplant recipients who were given 3 doses of the SARS-CoV-2 vaccine., In France, it has been allowed to offer a fourth dose on a case-by-case basis. We assessed whether a fourth dose of the SARS-CoV-2 vaccine is associated with improved anti–SARS-CoV-2 antibody concentrations in solid organ transplant recipients in France.
Educational Objective
To identify the key insights or developments described in this article
View Full Course